David Ellis

David Ellis is a financial executive with over 20 years of experience in private equity investing and international mergers and acquisitions, with a particular interest and expertise in the IT and healthcare industries. His strategic direction, growth strategies, and M&A approach have made him a well-respected expert in the field. David is also a very selective angel investor who invests primarily in later-stage growth companies. David is a strong proponent of strengthening external relations and forming corporate partnerships to drive consistent growth for companies. With a B.Sc in chemistry and biophysics and a Ph.D. from the University of St Andrews, David is well-educated, and his academic qualifications add a significant value to his professional experience. Additionally, David completed the Senior Executive Program from the Massachusetts Institute of Technology - Sloan School of Management, which was a recognition of his expertise and interest in the world of finance.

David has held several board member and advisory board member positions with several companies, including SpeedTracs, The Pedowitz Group, IP2Biz, Metabolic Testing Services, Neural Signals Inc, and more. David was also a managing director at EGL Ventures, Inc., managing director at EGL Holdings, Inc., board member at Information Access Management, and director at Oxford Instruments plc.